# Carlisle Companies Inc: Form 10-Q for the period ended Mar 31, 2022

- Company: [Carlisle Companies Inc](/companies/csl.md) (CIK 790051)
- Form: 10-Q
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 13:22 ET
- Period: 2022-03-31
- Accession: 0000790051-22-000094
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/790051/000079005122000094/csl-20220331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/790051/000079005122000094/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-01-01 to 2022-03-31 | $1.50bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-01-01 to 2022-03-31 | $1.01bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months, 2022-01-01 to 2022-03-31 | $12.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2022-01-01 to 2022-03-31 | $203.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2022-01-01 to 2022-03-31 | $277.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-01-01 to 2022-03-31 | $22.6m | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-01-01 to 2022-03-31 | $60.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-01-01 to 2022-03-31 | $193.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-01-01 to 2022-03-31 | $3.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-01-01 to 2022-03-31 | $3.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-01-01 to 2022-03-31 | 52,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2022-01-01 to 2022-03-31 | $44.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2022-01-01 to 2022-03-31 | $31.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2022-01-01 to 2022-03-31 | $28.7m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2022-01-01 to 2022-03-31 | $125.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2022-03-31 | $2.23bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-03-31 | $7.32bn | us-gaap:Assets |
| Current liabilities | at 2022-03-31 | $1.19bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2022-03-31 | $2.58bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-03-31 | $352.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-03-31 | $2.68bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 35,913 characters.

Carlisle Companies Incorporated (“Carlisle”, the “Company”, “we”, “us” or “our”) is a leading supplier of innovative building envelope products and energy-efficient solutions for customers creating sustainable buildings of the future. Through its Carlisle Construction Materials ("CCM") and Carlisle Weatherproofing Technologies ("CWT") businesses and family of leading brands, Carlisle delivers innovative, labor-reducing and environmentally responsible products and solutions to customers across the world through the Carlisle Experience. Over the life of a building, Carlisle’s products help drive lower greenhouse gas emissions, improve energy savings for building owners and operators, and increase a building’s resiliency to the elements. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior stockholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Carlisle also is a leading provider of products to the aerospace, medical technologies and general industrial markets through its Carlisle Interconnect Technologies ("CIT") and Carlisle Fluid Technologies ("CFT") business segments.

Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with a narrative from the perspective of Company management. All references to "Notes" refer to our Notes to Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report on Form 10-Q.

### Executive Overview

As we move into the second quarter of 2022 and realize the benefits of the diminishing effects of the COVID-19 pandemic, we are saddened by the continued humanitarian crisis occurring in Ukraine. While a majority of our business is North American focused, and we have minimal direct exposure to Russia and Ukraine, we are monitoring any broader economic impact from the current crisis, especially on commodities, and geographic proximity to the rest of Europe, where we conduct business. We hope peace and resolution will come quickly to the conflict.

The entire Carlisle team drove outstanding performance in the first quarter, while navigating continuing and unprecedented demand, supply chain constraints, and industry-wide labor and raw material challenges. CCM and CWT continue to benefit from strong re-roofing demand, solid new construction demand, and a growing push to install energy-efficient solutions. Our teams continue to secure raw materials, appropriately staff at all levels, and strive to meet our customers' expectations. Our goal is to always deliver the Carlisle Experience. Our proactive and value-added approach to pricing enabled us to neutralize the effects of significant raw material inflation last year and offset continued pressures we experienced in the first quarter, which we expect will persist throughout 2022. The integration of ASP Henry Holdings, Inc. ("Henry") continues to exceed expectations and deliver on our synergy commitments. Additionally, CIT's backlog continues to grow, driven by the recertification and accelerating deliveries of the 737 MAX, the anticipated resumption of 787 deliveries later this year, and improved capital spending in medical markets.

Our pivot towards our highest returning building products businesses that began in 2017 continues to prove to be the right strategic direction for Carlisle, which is reflected in our record first quarter sales and profits. We have invested $1.2 billion over the past decade to expand capacity, drive innovation, and develop world-class processes without which, our record results would not be possible.

Our business model continues to follow environmental, social and governance ("ESG") trends as our products enable a more efficient usage of energy by buildings. We continue to make progress toward our goal of delivering a net zero commitment in 2022.

We remain committed to superior capital allocation, which includes returning capital to stockholders. In the first quarter of 2022, we returned $28.7 million in the form of dividends. We also repurchased $125.0 million of shares, bringing our cumulative share repurchases since 2017 to over $1.9 billion, driving a 19.5% net reduction in our shares outstanding.

With demand accelerating across our businesses, and our new segment structure in place to focus our teams, Carlisle is well positioned to drive continued profitable growth in 2022 and deliver Vision 2025.

### Summary of Financial Results

*(in millions, except per share amounts)*

|  | Three Months Ended March 31, 2022 | 2021 |
| --- | ---: | ---: |
| Revenues | $1,496.3 | $940.9 |
| Operating income | $277.3 | $84.7 |
| Operating margin | 18.5% | 9.0% |
| Income from continuing operations | $194.3 | $49.1 |
| (Loss) income from discontinued operations | $(0.7) | $3.1 |
| Diluted earnings per share attributable to common shares: |  |  |
| Income from continuing operations | $3.67 | $0.91 |
| (Loss) income from discontinued operations | $(0.01) | $0.06 |
| Adjusted EBITDA(1) | $344.8 | $137.8 |
| Adjusted EBITDA margin(1) | 23.0% | 14.6% |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

Revenues increased in the first quarter of 2022 primarily reflecting price realization and higher volumes in all segments and contributions from the acquisition of Henry in the CWT segment, partially offset by unfavorable foreign currency impacts.

The increase in operating margin percentage in the first quarter of 2022 primarily reflected price realization, higher volumes and savings from the Carlisle Operating System ("COS"), partially offset by raw material and wage inflation across all segments.

Diluted earnings per share from continuing operations increased primarily due to improved operating income performance ($2.72 per share in the first quarter of 2022) and reduced average shares outstanding ($0.05 per share in the first quarter of 2022) resulting from purchases under our share repurchase program, partially offset by a higher effective tax rate ($0.03 per share in the first quarter of 2022).

We generated $44.3 million in operating cash flow in the first three months of 2022 and utilized cash on hand and cash provided by operations to return capital to stockholders through dividends and share repurchases, and to fund capital expenditures.

### Consolidated Results of Operations

### Revenues

*(in millions)*

|  | 2022 | 2021 | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Three months ended March 31 | $1,496.3 | $940.9 | $555.4 | 59.0% | 14.7% | 44.8% | (0.5)% |

Revenues increased in the first quarter of 2022 primarily reflecting price realization and higher sales volumes across all segments and contributions from the acquisition of Henry in the CWT segment, partially offset by unfavorable foreign currency impacts.

### Gross Margin

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Gross margin | $490.9 | $244.9 | $246.0 | 100.4% |
| Gross margin percentage | 32.8% | 26.0% |  |  |
| Depreciation and amortization | $27.0 | $24.6 |  |  |

Gross margin percentage (gross margin expressed as a percentage of revenues) increased in the first quarter of 2022, driven by price realization and higher volumes, partially offset by raw material and wage inflation. Also included in cost of goods sold were exit and disposal costs totaling $1.9 million for the first quarter of 2022, primarily at CIT attributable to our restructuring initiatives, compared with $0.8 million for the first quarter of 2021. Refer to Note 8 for further information on exit and disposal activities.

### Selling and Administrative Expenses

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Selling and administrative expenses | $203.0 | $150.8 | $52.2 | 34.6% |
| As a percentage of revenues | 13.6% | 16.0% |  |  |
| Depreciation and amortization | $37.3 | $24.2 |  |  |

The increase in selling and administrative expenses in the first quarter of 2022 primarily reflected incremental costs in the CWT segment from the addition of Henry, higher incentive compensation costs and wage inflation. Also included in selling and administrative expenses were exit and disposal costs totaling $0.3 million for the first quarter of 2022, primarily at CIT attributable to our restructuring initiatives, compared with $0.6 million for the first quarter of 2021. Refer to Note 8 for further information on exit and disposal activities.

### Research and Development Expenses

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development expenses | $12.3 | $10.4 | $1.9 | 18.3% |
| As a percentage of revenues | 0.8% | 1.1% |  |  |
| Depreciation and amortization | $0.4 | $0.5 |  |  |

Research and development expenses were higher in the first quarter of 2022, compared with the 2021, primarily reflecting higher new product development expenses at our CIT and CWT segments.

### Other Operating Income, net

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Other operating income, net | $(1.7) | $(1.0) | $(0.7) | 70.0% |

Other operating income, net in the first quarter of 2022 primarily reflected $1.0 million of rebates and $0.5 million of royalty income. Other operating income, net in the first quarter of 2021 primarily reflected $0.9 million of rebates and $0.3 million of royalty income.

### Operating Income

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Operating income | $277.3 | $84.7 | $192.6 | 227.4% |
| Operating margin percentage | 18.5% | 9.0% |  |  |

Refer to *Segment Results of Operations* within this MD&A for further information related to segment operating income results.

### Interest Expense, net

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Interest expense, net | $22.6 | $19.2 | $3.4 | 17.7% |

Interest expense, net of capitalized interest, increased in the first quarter of 2022 primarily reflecting higher long-term debt balances associated with our public offering of $550.0 million of 2.20% unsecured senior notes and $300.0 million of 0.55% unsecured senior notes completed in September 2021. Refer to Note 12 for further information on our long-term debt.

### Interest Income

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Interest income | $(0.2) | $(0.5) | $0.3 | (60.0)% |

Interest income decreased during the first quarter of 2022 primarily reflecting lower cash balances and lower yields.

### Other Non-operating Expense, net

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | --- |
| Other non-operating expense, net | $0.1 | $3.6 | $(3.5) | NM |

Other non-operating expense, net, in the first quarter of 2021 primarily reflected the release of a portion of the indemnification asset related to the acquisition of Petersen Aluminum Corporation resulting from escrow expirations and changes in foreign currencies against the U.S. Dollar.

### Income Taxes

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | ---: |
| Provision for income taxes | $60.5 | $13.3 | $47.2 | 354.9% |
| Effective tax rate | 23.7% | 21.3% |  |  |

The effective income tax rate on continuing operations for the first quarter of 2022 was 23.7%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 23.9% and a tax impact of $0.4 million related to discrete activity.

The effective income tax rate on continuing operations for the first quarter of 2021 was 21.3%.

### (Loss) Income from Discontinued Operations

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  |
| --- | ---: | ---: | ---: | --- |
| (Loss) income from discontinued operations before income taxes | $(0.7) | $4.5 | $(5.2) | NM |
| Provision for income taxes | — | 1.4 |  |  |
| (Loss) income from discontinued operations | $(0.7) | $3.1 |  |  |

Loss from discontinued operations in the first quarter of 2022 reflects transaction expenses associated with the 2021 sale of the equity interests and assets comprising the Carlisle Brake & Friction ("CBF") segment. Income from discontinued operations in the first quarter of 2021 reflects the operating results from the CBF segment.

### Segment Results of Operations

### Carlisle Construction Materials

This segment produces a complete line of premium single-ply roofing products and warranted roof systems and accessories for the commercial building industry, including polyiso insulation and engineered metal roofing and wall panel systems.

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $881.1 | $556.4 | $324.7 | 58.4% | —% | 58.9% | (0.5)% |
| Operating income | $261.1 | $110.7 | $150.4 | 135.9% |  |  |  |
| Operating margin | 29.6% | 19.9% |  |  |  |  |  |
| Adjusted EBITDA(1) | $275.3 | $123.9 | $151.4 | 122.2% |  |  |  |
| Adjusted EBITDA margin(1) | 31.2% | 22.3% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CCM’s revenue increased in the first quarter of 2022 primarily reflecting price realization and higher volumes from strength in U.S. commercial roofing demand.

CCM’s operating margin and adjusted EBITDA margin increase in the first quarter of 2022 primarily reflected price realization, higher volumes, improved product mix and savings from COS, partially offset by raw material and wage inflation.

### Carlisle Weatherproofing Technologies

This segment produces building envelope solutions that effectively drive energy efficiency and sustainability in commercial and residential applications. Products include high-performance waterproofing and moisture protection products, protective roofing underlayments, fully integrated liquid and sheet applied air/vapor barriers, sealants/primers and flashing systems, roof coatings and mastics, spray polyurethane foam and coating systems for a wide variety of thermal protection applications and other premium polyurethane products, block-molded expanded polystyrene insulation, engineered products for HVAC applications, and premium rubber products for a variety of industrial and surfacing applications.

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $359.1 | $162.9 | $196.2 | 120.4% | 84.7% | 36.0% | (0.3)% |
| Operating income | $37.5 | $10.6 | $26.9 | 253.8% |  |  |  |
| Operating margin | 10.4% | 6.5% |  |  |  |  |  |
| Adjusted EBITDA(1) | $63.1 | $20.9 | $42.2 | 201.9% |  |  |  |
| Adjusted EBITDA margin(1) | 17.6% | 12.8% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin are intended to provide investors and others with information about Carlisle and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CWT’s revenue increased in the first quarter of 2022 primarily reflecting price realization, higher volumes and contributions from the Henry acquisition.

CWT’s operating margin and adjusted EBITDA margin increase in the first quarter of 2022 primarily reflected price realization, higher volumes and contributions from the Henry acquisition, partially offset by raw material and wage inflation. CWT's operating margin also reflected amortization of intangible assets from the Henry acquisition.

### Carlisle Interconnect Technologies

This segment produces high-performance wire and cable, including optical fiber, for the commercial aerospace, military and defense electronics, medical device, industrial, and test and measurement markets. CIT's product portfolio also includes sensors, connectors, contacts, cable assemblies, complex harnesses, racks, trays, and installation kits, in addition to engineering and certification services. CIT also provides medical device products and solutions for several medical technology applications.

During the third quarter of 2021, we announced the closure of our manufacturing operations in Carlsbad, California, and the relocation of those operations to our existing facilities in North America. The project is estimated to take a remaining nine to 12 months to complete. Total projected costs are expected to approximate $5.8 million, with approximately $3.0 million costs remaining to be incurred.

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $185.0 | $155.8 | $29.2 | 18.7% | —% | 18.7% | —% |
| Operating loss | $(2.5) | $(10.7) | $8.2 | 76.6% |  |  |  |
| Operating margin | (1.4)% | (6.9)% |  |  |  |  |  |
| Adjusted EBITDA(1) | $18.4 | $11.0 | $7.4 | 67.3% |  |  |  |
| Adjusted EBITDA margin(1) | 9.9% | 7.1% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin is intended to provide investors and others with information about Carlisle's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CIT's revenue increased in the first quarter of 2022 primarily reflecting higher volumes, as recovery has begun in the commercial aerospace market, and price realization.

CIT’s operating margin and adjusted EBITDA margin improvement in the first quarter of 2022 was driven by savings from COS and lower travel and other administrative costs, partially offset by wage inflation, unfavorable foreign currency impacts and unfavorable mix.

### Carlisle Fluid Technologies

This segment produces highly engineered liquid, powder, sealants and adhesives finishing equipment and integrated system solutions for spraying, pumping, mixing, metering and curing of a variety of coatings used in the automotive manufacture, general industrial, protective coating, wood, specialty and automotive refinishing markets.

*(in millions)*

| 2022 | Three Months Ended March 31, 2021 |  | Change% |  | Acquisition Effect | Price / Volume Effect | Exchange Rate Effect |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenues | $71.1 | $65.8 | $5.3 | 8.1% | —% | 9.9% | (1.8)% |
| Operating income | $4.8 | $4.3 | $0.5 | 11.6% |  |  |  |
| Operating margin | 6.8% | 6.5% |  |  |  |  |  |
| Adjusted EBITDA(1) | $10.5 | $10.2 | $0.3 | 2.9% |  |  |  |
| Adjusted EBITDA margin(1) | 14.8% | 15.5% |  |  |  |  |  |

(1) Adjusted EBITDA and adjusted EBITDA margin is intended to provide investors and others with information about Carlisle's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CFT's revenue increased in the first quarter of 2022 reflecting increased volumes, particularly in the transportation end market, and price realization, partially offset by unfavorable foreign currency impacts.

CFT’s operating margin performance improved for the first quarter of 2022, reflecting price realization, higher volumes, lower restructuring expenses, and savings from COS, partially offset by raw material, wage and freight inflation and unfavorable mix.

CFT’s adjusted EBITDA margin decreased in the first quarter of 2022, reflecting higher raw material, wage and freight inflation and unfavorable mix, partially offset by price realization, higher volumes, and savings from COS.

### Liquidity and Capital Resources

A summary of our cash and cash equivalents by region follows:

*(in millions)*

|  | March 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Europe | $77.3 | $12.3 |
| North America (excluding U.S.) | 29.8 | 40.8 |
| China | 21.9 | 17.8 |
| Asia Pacific (excluding China) | 22.0 | 12.9 |
| International cash and cash equivalents | 151.0 | 83.8 |
| U.S. cash and cash equivalents | 140.7 | 240.6 |
| Total cash and cash equivalents | $291.7 | $324.4 |

We maintain liquidity sources primarily consisting of cash and cash equivalents as well as availability under the Company's Fourth Amended and Restated Credit Agreement (as amended, the "Facility"). In the near term, cash on hand is our primary source of liquidity. The decrease in cash and cash equivalents compared to December 31, 2021, is primarily related to share repurchases, payment of dividends to stockholders and capital expenditures, partially offset by the receipt of the $125 million earn out payment from the sale of CBF.

In certain countries, primarily China, our cash is subject to local laws and regulations that require government approval for conversion of such cash to U.S. Dollars, as well as for transfer of such cash, both temporarily and permanently outside of that jurisdiction. In addition, upon permanent transfer of cash outside of certain jurisdictions, primarily in Canada and China, we may be subject to withholding taxes, and as such we have accrued $10.4 million in anticipation of those taxes as of March 31, 2022.

We believe we have sufficient cash on hand, availability under the Facility and operating cash flows to meet our anticipated business requirements for at least the next 12 months. At the discretion of management, the Company may use available cash on capital expenditures, dividends, common stock repurchases, acquisitions and strategic investments.

We also anticipate we will have sufficient cash on hand, availability under the Facility and operating cash flows to meet our anticipated long-term business requirements and to pay outstanding principal balances of our existing notes by the respective maturity dates. Another potential source of liquidity is access to public capital markets, subject to market conditions. We may access the capital markets to repay the outstanding balances of our outstanding debt. Refer to Note 12.

### Sources and Uses of Cash and Cash Equivalents

*(in millions)*

|  | Three Months Ended March 31, 2022 | 2021 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $44.3 | $67.6 |
| Net cash provided by (used in) investing activities | 81.2 | (28.4) |
| Net cash used in financing activities | (158.8) | (172.8) |
| Effect of foreign currency exchange rate changes on cash | 0.6 | (1.4) |
| Change in cash and cash equivalents | $(32.7) | $(135.0) |

#### Operating Activities

We generated operating cash flows of $44.3 million for the first three months of months of 2022 (including working capital uses of $229.9 million), compared with $67.6 million for the first three months of months of 2021 (including working capital uses of $54.0 million). Lower operating cash flows in the first the first three months of months of 2022 primarily reflected an increase in receivables from higher sales and an increase in inventory from rising raw material costs and increased volume, partially offset by higher payables due to rising raw material costs.

#### Investing Activities

Cash provided by investing activities of $81.2 million for the first three months of months of 2022 primarily reflected the proceeds of the contingent consideration from the sale of CBF of $125.0 million and proceeds from investment in securities of $10.3 million, partially offset by capital expenditures of $31.1 million and the acquisition of MBTechnology for $24.7 million. Cash used in investing activities of $28.4 million for the first three months of months of 2021 primarily reflected capital expenditures of $20.0 million and investment in securities of $10.2 million.

#### Financing Activities

Cash used in financing activities of $158.8 million in the first three months of months of 2022 primarily reflected share repurchases of $125.0 million and cash dividend payments of $28.7 million, reflecting the increased quarterly dividend of $0.54 per share. Cash used in financing activities of $172.8 million during the first three months of months of 2021 primarily reflected share repurchases of $150.0 million and dividend payments of $28.4 million.

### Debt Instruments

#### Revolving Credit Facility

During the first three months of months of 2022 and 2021, we had no borrowings or repayments under the Facility. As of March 31, 2022 and December 31, 2021, the Facility had no outstanding balance and $1.0 billion available for use.

#### Debt Covenants

We are required to meet various covenants and limitations under our senior notes and Facility, including certain leverage ratios, interest coverage ratios and limits on outstanding debt balances held by certain subsidiaries. We were in compliance with all covenants and limitations as of March 31, 2022 and December 31, 2021.

Refer to Note 12 for further information on our debt instruments.

### Non-GAAP Financial Measures

### EBIT, Adjusted EBIT, Adjusted EBITDA and Adjusted EBITDA Margin

Earnings before interest and taxes ("EBIT"), adjusted EBIT, adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA margin are intended to provide investors and others with information about the Company's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to similarly-situated companies. This information differs from net income, operating income, and operating margin determined in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and should not be considered in isolation or as a substitute for measures of performance determined in accordance with U.S. GAAP. The Company's and its segments' EBIT, adjusted EBIT, adjusted EBITDA and adjusted EBITDA margin follows. These non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.

*(in millions)*

|  | Three Months Ended March 31, 2022 | 2021 |
| --- | ---: | ---: |
| Net income (GAAP) | $193.6 | $52.2 |
| Less: (loss) income from discontinued operations (GAAP) | (0.7) | 3.1 |
| Income from continuing operations (GAAP) | 194.3 | 49.1 |
| Provision for income taxes | 60.5 | 13.3 |
| Interest expense, net | 22.6 | 19.2 |
| Interest income | (0.2) | (0.5) |
| EBIT | 277.2 | 81.1 |
| Exit and disposal, and facility rationalization costs | 2.1 | 3.1 |
| Inventory step-up amortization and acquisition costs | — | 0.9 |
| Impairment charges | 0.2 | — |
| Losses from acquisitions and disposals | 0.3 | 3.4 |
| Losses from insurance | 0.3 | — |
| Total non-comparable items | 2.9 | 7.4 |
| Adjusted EBIT | 280.1 | 88.5 |
| Depreciation | 24.0 | 20.3 |
| Amortization | 40.7 | 29.0 |
| Adjusted EBITDA | $344.8 | $137.8 |
| Divided by: |  |  |
| Total revenues | $1,496.3 | $940.9 |
| Adjusted EBITDA margin | 23.0% | 14.6% |

27

*(in millions)*

|  | Three Months Ended March 31, 2022 CCM | CWT | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $261.1 | $37.5 | $(2.5) | $4.8 | $(23.6) |
| Non-operating expense (income)(1) | — | 0.1 | (0.5) | 0.1 | 0.4 |
| EBIT | 261.1 | 37.4 | (2.0) | 4.7 | (24.0) |
| Exit and disposal, and facility rationalization costs | — | 0.1 | 2.0 | — | — |
| Inventory step-up amortization and acquisition costs | — | (0.1) | — | — | 0.1 |
| Impairment charges | — | 0.2 | — | — | — |
| Losses from acquisitions and disposals | — | — | 0.2 | 0.1 | — |
| Losses from insurance | — | 0.3 | — | — | — |
| Total non-comparable items | — | 0.5 | 2.2 | 0.1 | 0.1 |
| Adjusted EBIT | 261.1 | 37.9 | 0.2 | 4.8 | (23.9) |
| Depreciation | 9.2 | 6.3 | 6.1 | 1.5 | 0.9 |
| Amortization | 5.0 | 18.9 | 12.1 | 4.2 | 0.5 |
| Adjusted EBITDA | $275.3 | $63.1 | $18.4 | $10.5 | $(22.5) |
| Divided by: |  |  |  |  |  |
| Total revenues | $881.1 | $359.1 | $185.0 | $71.1 | $— |
| Adjusted EBITDA margin | 31.2% | 17.6% | 9.9% | 14.8% | NM |

(1) Includes other non-operating expense (income), which may be presented in separate line items on the Condensed Consolidated Statements of Income.

*(in millions)*

|  | Three Months Ended March 31, 2021 CCM | CWT | CIT | CFT | Corporate and unallocated |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating income (loss) (GAAP) | $110.7 | $10.6 | $(10.7) | $4.3 | $(30.2) |
| Non-operating expense (income)(1) | 2.3 | (0.1) | — | 0.4 | 1.0 |
| EBIT | 108.4 | 10.7 | (10.7) | 3.9 | (31.2) |
| Exit and disposal, and facility rationalization costs | — | — | 2.5 | 0.6 | — |
| Inventory step-up amortization and acquisition costs | — | — | — | 0.1 | 0.8 |
| Losses from acquisitions and disposals | 2.3 | — | 0.3 | — | 0.8 |
| Total non-comparable items | 2.3 | — | 2.8 | 0.7 | 1.6 |
| Adjusted EBIT | 110.7 | 10.7 | (7.9) | 4.6 | (29.6) |
| Depreciation | 9.2 | 2.7 | 6.3 | 1.2 | 0.9 |
| Amortization | 4.0 | 7.5 | 12.6 | 4.4 | 0.5 |
| Adjusted EBITDA | $123.9 | $20.9 | $11.0 | $10.2 | $(28.2) |
| Divided by: |  |  |  |  |  |
| Total revenues | $556.4 | $162.9 | $155.8 | $65.8 | $— |
| Adjusted EBITDA margin | 22.3% | 12.8% | 7.1% | 15.5% | NM |

(1) Includes other non-operating expense (income), which may be presented in separate line items on the Condensed Consolidated Statements of Income.

### Outlook

Our expectations for segment and total revenues for 2022, compared to 2021 follow:

|  | 2022 Revenue | Primary Drivers |
| --- | --- | --- |
| Carlisle Construction Materials | ~30% growth | •Proactive pricing measures gaining traction •Strong re-roofing demand •Increasing demand for energy-efficient building products |
| Carlisle Weatherproofing Technologies | ~55 to 60% growth | •Henry acquisition •Strong demand in all product lines |
| Carlisle Interconnect Technologies | Low double-digit growth | •Growing commercial aerospace and medical backlogs |
| Carlisle Fluid Technologies | ~10% growth | •Focus on new product introductions and price discipline •Markets strengthening |
| Total Carlisle | Over 30% growth |  |

For the year 2022, we expect:

- Corporate expenses of approximately $120 million;
- Depreciation and amortization expense of approximately $250 million;
- Capital expenditures of approximately $175 million;
- Interest expense, net of interest income, of approximately $90 million; and
- Base tax rate of approximately 24-25%.

### Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the potential or expected impacts of the global COVID-19 pandemic. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties. It is possible that our future performance may differ materially from current expectations expressed in these forward-looking statements, due to a variety of factors such as: risks from the global COVID-19 pandemic, including, for example, expectations regarding the impact of the COVID-19 pandemic on our businesses, including on customer demand, supply chains and distribution systems, production, our ability to maintain appropriate labor levels, our ability to ship products to our customers, our future results, or our full-year financial outlook; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost-effective basis; our mix of products/services; increases in raw material costs that cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental and industry regulations; threats associated with and efforts to combat terrorism; protection and validity of patent and other intellectual property rights; the identification of strategic acquisition targets and our successful completion of any transaction and integration of our strategic acquisitions; our successful completion of strategic dispositions; the cyclical nature of our businesses; the impact of information technology, cybersecurity or data security breaches at our businesses or third parties; and the outcome of pending and future litigation and governmental proceedings; and the other factors discussed in the reports we file with or furnish to the Securities and Exchange Commission from time to time. In addition, such statements could be affected by general industry and market conditions and growth rates, the condition of the financial and credit markets and general domestic and international economic conditions, including inflation and interest rate and currency exchange rate fluctuations. Further, any conflict in the international arena, including the Russian invasion of Ukraine, may adversely affect general market conditions and our future performance. Any forward-looking statement speaks only as of the date on which that statement is made, and we undertake no duty to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date on which that statement is made, unless otherwise required by law. New factors emerge from time to time and it is not possible for management to predict all of those factors, nor can it assess the impact of each of those factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement.

## Market risk

As filed, 272 characters.

There have been no material changes in the Company’s market risk for the three months ended March 31, 2022. For additional information, refer to "PART II—Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the Company’s 2021 Annual Report on Form 10-K.

## Controls and procedures

As filed, 1,724 characters.

a. Evaluation of disclosure controls and procedures. Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation and as of March 31, 2022, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.

b. Changes in internal controls. During third quarter of 2021, the Company completed its acquisition of ASP Henry Holdings, Inc. (“Henry”). This acquisition is material to the Company's results of operations, financial position and cash flows. Refer to Note 3 for additional information regarding the Henry acquisition.

The Company is currently in the process of integrating Henry, including internal controls and procedures and extending its Sarbanes-Oxley Act Section 404 compliance program to include Henry. The Company anticipates a successful integration of Henry's operations and internal controls and procedures and will continue to evaluate its internal control over financial reporting as the Company executes integration activities. The Company's assessment of the effectiveness of controls and procedures for the year ended December 31, 2022, will include Henry.

During the first the first three months of months of 2022, there were no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

## Risk factors

As filed, 149 characters.

There have been no material changes in the Company's risk factors disclosed in "PART I—Item 1A. Risk Factors" in our 2021 Annual Report on Form 10-K.

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0000790051-22-000094. Last ingested by Listed: Nov 10, 2026, 16:42 ET. No prices; not investment advice.
